Lenvatinib in multimodal therapy for unresectable radioactive iodine‐naïve differentiated thyroid cancer: A case report with literature review

Lenvatinib in multimodal therapy for unresectable radioactive iodine‐naïve differentiated thyroid cancer: A case report with literature review

Abstract Background Patients with unresectable or metastatic differentiated thyroid carcinoma (DTC) are rare and require individualized therapy. This may require approaches not typically used in resectable disease. We report a patient treated with lenvatinib and external beam radiation therapy. Case...

Full description

Bibliographic Details
Main Authors: Hugh Andrew Jinwook Kim, Anthony Charles Nichols, Ramanamurthy Rachakonda, Richard Inculet, Jinka Sathya, Irina Rachinsky, Eric Winquist
Format: Article
Language:English
Published: Wiley 2022-10-01
Series:Cancer Reports
Subjects:
cancer care
cancer management
cancer medicine
clinical observations
head and neck cancer
immunotherapy
Online Access:https://doi.org/10.1002/cnr2.1654

Internet

https://doi.org/10.1002/cnr2.1654

Similar Items